Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institute For Atherosclerosis Research, Russia

Clinical trials sponsored by Institute For Atherosclerosis Research, Russia, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a green tea compound prevent second heart attacks? Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Could a green tea compound prevent second heart attacks?

Disease control Ongoing

This trial tests whether a dietary supplement called Tertinat, containing epigallocatechin-3-gallate, can reduce major heart problems in people with atherosclerosis who have recently had bypass or stent surgery. Over two years, participants take either the supplement or a placebo…

Phase 2 • Sponsor: Institute for Atherosclerosis Research, Russia • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC